Becton Dickinson & Company BD Ultra-Fine Pen Needles 32G x 4mm (5/32' )-intended for parenteral administration of a drug from a cartridge contained in a drug pen injector Catalog Number: 320122 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
BD Ultra-Fine Pen Needles 32G x 4mm (5/32' )-intended for parenteral administration of a drug from a cartridge contained in a drug pen injector Catalog Number: 320122
Brand
Becton Dickinson & Company
Lot Codes / Batch Numbers
Batch Number: 9352052 Exp. Date: 20241231
Products Sold
Batch Number: 9352052 Exp. Date: 20241231
Becton Dickinson & Company is recalling BD Ultra-Fine Pen Needles 32G x 4mm (5/32' )-intended for parenteral administration of a drug from a due to Product shelf cartons incorrectly labeled as products intended for the Latin American market. Although the product description on the label 32G x 4mm. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Product shelf cartons incorrectly labeled as products intended for the Latin American market. Although the product description on the label 32G x 4mm pen needles is correct, information pertinent to users in the US regarding compatibility with specific pen needles is missing.
Recommended Action
Per FDA guidance
BD consignees and distributors notified on October 23, 2020 via hard copy letter sent via Federal Express (FedEx) and/or email, when available. Letter states reason for recall, health risk and action to take: 1. Immediately review your inventory for the specific Catalog (Ref) and Lot number specified in this notification and discard all product subject to the recall. 2. Share this recall notification with pharmacy staff at all applicable pharmacy locations and display the letter where it is visible to all to ensure awareness of this recall Distributors are requested to identify their customers and provide BD a customer list. BD will notify these customers via FedEx. 3. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification and process your product replacement order, accordingly. 4. This recall is being conducted at the wholesaler/hospital/retail level only. There is no need to notify users who may have already purchased the device, as the product itself is not defective and presents no risk to users. Actions Taken by BD: " Replacement product will be provided for all discarded inventory. Contact Information: If you require further assistance, please contact: BD Contact Information: BD Customer/Technical Support (844) 823-5433 Mon Fri 8:30am - 5:00pm (CST
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026